RICCERI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 1.366
EU - Europa 632
AS - Asia 581
SA - Sud America 66
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 14
OC - Oceania 9
Totale 2.688
Nazione #
US - Stati Uniti d'America 1.332
IT - Italia 234
RU - Federazione Russa 180
SG - Singapore 136
CN - Cina 132
BD - Bangladesh 100
SE - Svezia 69
VN - Vietnam 59
BR - Brasile 52
HK - Hong Kong 39
DE - Germania 37
IE - Irlanda 37
KR - Corea 34
JP - Giappone 22
CA - Canada 21
FR - Francia 20
FI - Finlandia 18
GB - Regno Unito 18
JO - Giordania 14
IN - India 12
TR - Turchia 11
AU - Australia 9
NL - Olanda 6
EC - Ecuador 4
IQ - Iraq 4
CH - Svizzera 3
EG - Egitto 3
JM - Giamaica 3
MX - Messico 3
PK - Pakistan 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AL - Albania 2
AR - Argentina 2
BE - Belgio 2
CL - Cile 2
CO - Colombia 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
SC - Seychelles 2
VE - Venezuela 2
BB - Barbados 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
GT - Guatemala 1
HN - Honduras 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PL - Polonia 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UY - Uruguay 1
Totale 2.668
Città #
Ashburn 194
Santa Clara 175
Fairfield 94
Singapore 87
San Jose 71
Chandler 64
Woodbridge 62
Seattle 51
Houston 48
Council Bluffs 45
Milan 39
Dublin 37
Cambridge 34
Seoul 33
Buffalo 32
Hong Kong 31
Rome 30
Wilmington 29
Los Angeles 24
New York 23
Hefei 22
Tokyo 22
Beijing 20
Phoenix 20
Altamura 19
Florence 19
Munich 19
Ann Arbor 17
Lawrence 16
Ho Chi Minh City 13
The Dalles 13
Dallas 12
Lauterbourg 12
Jacksonville 11
Naples 9
Princeton 9
Boardman 8
Boston 8
Hanoi 8
Chicago 7
Izmir 7
Turin 7
Turku 7
Da Nang 6
Genoa 6
Melbourne 6
Palermo 6
San Diego 6
Shanghai 6
Hillsboro 5
Toronto 5
Atlanta 4
Bengaluru 4
Cagliari 4
Catania 4
London 4
Paris 4
Amsterdam 3
Brasília 3
Brescia 3
Brooklyn 3
Denver 3
Frankfurt am Main 3
Helsinki 3
Johannesburg 3
Kent 3
Miami 3
Montreal 3
Moscow 3
Mumbai 3
Norwalk 3
Orem 3
Padua 3
Pescara 3
Reggio Emilia 3
Tashkent 3
Tianjin 3
Bari 2
Bern 2
Brampton 2
Brussels 2
Campinas 2
Cento 2
Charlotte 2
Cleveland 2
Erbil 2
Falkenstein 2
Fayetteville 2
Figino 2
Hortolândia 2
Hải Dương 2
Kingston 2
Lancaster 2
Las Vegas 2
Lockport 2
Mascalucia 2
Medford 2
Miano 2
Milwaukee 2
Neumarkt 2
Totale 1.684
Nome #
Atopic dermatitis. 237
Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. 237
The importance of genetical link in immuno-mediated dermatoses: psoriasis and vitiligo. 214
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 214
Psoriasis and body mass index. 204
Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities. 199
Quantity, distribution and immunophenotypical modification of dendritic cells upon biological treatments in psoriasis. 171
NADPH Oxidase 4 as a Source of Oxidative Stress in Fibroblasts From Patients Affected by Psoriasis 167
Photodynamic treatment for viral infections of the skin. 163
Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits 121
Treatment of severe nail psoriasis with acitretin: An impressive therapeutic result 101
Therapy of PsO in Special Subsets of Patients 99
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study 88
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study 69
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation 55
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics 55
Risankizumab in Oncologic Patients With Psoriasis: A Case Series 40
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study 34
Age affects drug survival rates of interleukin (IL)‐17 and IL‐23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi‐country, cohort study 31
Risankizumab in very elderly patients in real-world practice 30
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study 26
Gottron papules: a pathognomonic sign of dermatomyositis 22
Etanercept restores a differentiated keratinocyte phenotype in psoriatic human skin: a morphological study 22
Etanercept therapy in a hepatitis B virus (HBV)‐positive psoriatic patient developing a monoclonal gammopathy of undetermined significance 21
Successful use of anti‐IL ‐23 molecules in overweight‐to‐obese psoriatic patients: A multicentric retrospective study 20
Development of monoclonal gammopathy in 12 patients receiving efalizumab treatment for chronic plaque psoriasis 18
Induction of apoptosis by fractional CO 2 laser treatment 17
Reply 13
Totale 2.688
Categoria #
all - tutte 7.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202248 0 0 0 1 1 1 2 8 1 0 20 14
2022/2023225 16 56 9 22 20 33 20 8 31 3 3 4
2023/202460 2 8 11 3 4 13 4 6 1 1 5 2
2024/2025508 25 44 27 65 145 78 15 21 29 7 30 22
2025/20261.124 87 93 62 26 102 23 72 37 159 120 78 265
2026/2027271 40 47 136 48 0 0 0 0 0 0 0 0
Totale 2.688